resveratrol has been researched along with Cardiovascular Stroke in 71 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (1.41) | 18.2507 |
| 2000's | 27 (38.03) | 29.6817 |
| 2010's | 32 (45.07) | 24.3611 |
| 2020's | 11 (15.49) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Li, H; Li, L; Li, T; Xie, J; Zhou, Y | 1 |
| Netticadan, T; Raj, P; Thandapilly, SJ; Wigle, J; Zieroth, S | 1 |
| Hamblin, MR; Khaksary Mahabady, M; Mirzaei, H; Ostadian, A; Razaghi Bahabadi, Z; Shafabakhsh, R; Sheida, A; Taghavi, T | 1 |
| Buttari, B; Profumo, E; Retamal, C; Rodrigo, R; Saha, S; Saso, L; Schupper, D; Vergara-Hernández, D | 1 |
| Lu, J; Ma, Y; Sun, L; Wang, S; Xue, P; Yu, J; Yue, X; Zhang, Y | 1 |
| Duan, QJ; Li, J; Shen, J | 1 |
| André, E; Balligand, JL; Bertrand, L; Bouzin, C; Brusa, D; De Pauw, A; Timmermans, A; Verdoy, R | 1 |
| Hu, Y; Kumar, P; Mishra, A; Moktan, JB; Sreeharsha, N; Sun, L; Wang, L | 1 |
| Accorsi, D; Campbell, JD; Lakshmanan, R; Maulik, N; McFadden, DW; Selvaraju, V; Thirunavukkarasu, M | 1 |
| Hallajzadeh, J; Mirsafaei, L; Reiner, Ž; Zivarpour, P | 1 |
| Esmaili Dahej, M; Hafizi Barjin, Z; Moradi, A; Safari, F; Soltan, F; Yadegari, M | 1 |
| Netticadan, T; Parikh, M; Raj, P; Sayfee, K; Wigle, J; Yu, L; Zieroth, S | 1 |
| Beker, DL; Byrne, NJ; Dyck, JRB; El-Kadi, AOS; Maayah, ZH; Masson, G; Matsumura, N; Parajuli, N; Shoieb, SM; Soltys, CM; Takahara, S | 1 |
| Feng, L; Kang, L; Li, J; Li, Y; Liu, J; Ma, C; Qi, Z; Ren, J; Yang, G; Yang, L; Zhang, S | 1 |
| Bernard, M; Desrois, M; Fourny, N; Lan, C; Sérée, E | 1 |
| Feng, HK; Hua, L; Huang, LF; Shen, B; Zhang, X | 1 |
| Liang, X; Lu, Y; Mao, Q; Wu, Y | 1 |
| Gilinsky, MA; Komarova, NI; Latysheva, TV; Naumenko, SE; Rogachev, AD; Salakhutdinov, NF; Tolstikov, GA | 1 |
| Gu, XS; Lei, JP; Li, L; Su, DF; Wang, ZB; Ye, Z; Zheng, X | 1 |
| Das, DK; Das, S; Mitrovsky, G; Vasanthi, HR | 1 |
| Cong, X; Dai, Y; Li, Y; Liu, Y; Lu, N; Zhang, H; Zhao, X | 1 |
| Aresu, G; Athanasakis, E; Avolio, E; Barchiesi, A; Beltrami, AP; Beltrami, CA; Caragnano, A; Cesselli, D; Emanueli, C; Finato, N; Gianfranceschi, G; Katare, R; Livi, U; Madeddu, P; Mazzega, E; Meloni, M; Palma, A; Scoles, G; Toffoletto, B; Vascotto, C | 1 |
| He, M; Lai, S; Liao, Z; Liu, D; Tang, L; Yao, J; Yin, D; Yin, S | 1 |
| Chen, J; Hai-Yan, Q; Hong, W; Jian-Feng, H; Jue, W; Qian, Z; Shou-Dong, W; Tatsuo, S; Yue-Jin, Y | 1 |
| Beauloye, C; Bertrand, L; Daskalopoulos, EP; Dufeys, C; Horman, S | 1 |
| Fekri, A; Hekmatimoghaddam, S; Klishadi, MS; Safari, F; Shekarforoush, S; Zarei, F | 1 |
| Aloud, BM; Louis, XL; Netticadan, T; Raj, P; Yu, L; Zieroth, S | 1 |
| Kang, L; Li, J; Liu, F; Liu, J; Qi, Z; Shen, Y; Wang, X; Wang, Y; Yang, L; Yang, Y; Zhang, J; Zhang, Q; Zhang, Y; Zhu, M | 1 |
| Otis, JS; Rogers, RG | 1 |
| Cheng, Y; Gu, S; Ling, L | 1 |
| Bagchi, D; Koneru, S; Maulik, G; Maulik, N; Menon, VP; Penumathsa, SV; Samuel, SM; Yet, SF | 1 |
| Cai, J; Chen, L; Chen, YR; Li, XY; Su, PX; Wang, CY; Yang, XC; Yi, FF | 1 |
| Liew, R | 1 |
| Mueller, RA; Norfleet, EA; Wang, H; Xi, J; Xu, Z | 1 |
| Maulik, N; Penumathsa, SV | 1 |
| Ahsan, MK; Bak, I; Das, DK; Gherghiceanu, M; Gurusamy, N; Juhasz, B; Lekli, I; Mukherjee, S; Popescu, LM; Ray, D; Tosaki, A | 1 |
| Hisahara, S; Horio, Y; Ishikawa, S; Kuno, A; Miura, T; Shimamoto, K; Tanno, M; Yano, T | 1 |
| Bernhagen, J; Bucala, R; Leng, L; Li, J; Ma, H; Merk, M; Ren, J; Thomas, DP; Tong, C; Wang, J; Wang, W; Zierow, S | 1 |
| Das, DK; Gurusamy, N; Lekli, I; Ray, D | 1 |
| Chen, C; Huang, S; Pan, Y; Wei, M; Xin, P; Zhu, W | 1 |
| Das, DK; Gesztelyi, R; Juhasz, A; Juhasz, B; Juhaz, B; Kertesz, A; Varga, B | 1 |
| Bak, I; Das, DK; Lekli, I; Mukherjee, S; Ray, D; Tosaki, A | 1 |
| Lacerda, L; Lamont, KT; Lecour, S; Opie, LH; Somers, S | 1 |
| Das, DK; Gorbunov, N; Gurusamy, N; Kim, DH; Petrovski, G; Ray, D | 1 |
| Huang, SS; Lin, JF; Lin, SM; Lu, BY; Tsai, SK; Wu, S | 1 |
| Battyany, I; Czopf, L; Feher, G; Fulop, A; Halmosi, R; Magyar, K; Palfi, A; Sumegi, B; Szabados, E; Toth, K | 1 |
| Gao, LJ; Li, P; Qian, HY; Wang, H; Wang, SD; Wang, TJ; Yang, YJ; Zhang, Q | 1 |
| Fujiwara, H; Fujiwara, T; Goto, K; Kanamori, H; Kawaguchi, T; Kawasaki, M; Mikami, A; Minatoguchi, S; Morishita, K; Ogino, A; Seishima, M; Takemura, G; Takeyama, T; Tsujimoto, A; Watanabe, T | 1 |
| Chen, JK; Hung, LM; Su, MJ | 1 |
| Cordis, GA; Das, DK; Das, S; Maulik, N | 1 |
| Szmitko, PE; Verma, S | 1 |
| Bagchi, D; Das, DK; Das, S; Maulik, N; Tosaki, A | 2 |
| Kaga, S; Matsumoto, M; Maulik, N; Zhan, L | 1 |
| Bertelli, A; Bollini, R; Das, DK; Das, S; Falchi, M; Lo Scalzo, R; Morelli, R | 1 |
| Bagchi, D; Bertelli, A; Das, DK; Fukuda, S; Kaga, S; Maulik, N; Zhan, L | 1 |
| Baur, JA; Sinclair, DA | 1 |
| Das, DK; Das, S; Fraga, CG | 1 |
| Juhasz, B; Koneru, S; Maulik, N; Menon, VP; Otani, H; Pant, R; Penumathsa, SV; Thirunavukkarasu, M; Zhan, L | 1 |
| Bertelli, A; Das, DK; Das, S; Falchi, M; Maulik, N | 1 |
| Agewall, S; Cruz, MN; Kublickiene, K; Schenck-Gustafsson, K | 1 |
| Burstein, B; Calderone, A; Clément, R; Ethier, N; Gosselin, H; Hébert, TE; Maguy, A; Nattel, S; Poulin, F; Tardif, JC | 1 |
| Bak, I; Das, DK; Das, M; Das, S; Gesztelyi, R; Juhasz, B; Lekli, I; Szabo, G; Szendrei, L; Tosaki, A; Varadi, J; Varga, E | 1 |
| Bertelli, A; Bertelli, AA; Cordis, GA; Das, DK; Maulik, G; Ray, PS | 1 |
| Bagchi, D; Das, DK; Maulik, G; Sato, M | 1 |
| Bertelli, A; Bertelli, AA; Das, DK; Engelman, RM; Maulik, G; Maulik, N; Ray, PS; Sato, M | 1 |
| Barenghi, L; Beemster, P; Bertelli, AA; Bradamante, S; De Jong, JW; De Jonge, R; Piccinini, F | 1 |
| Chen, JK; Hung, LM; Lee, RS; Liang, HC; Su, MJ | 1 |
| Hale, SL; Kloner, RA | 1 |
| Das, DK; Hattori, R; Maulik, N; Otani, H | 1 |
| Bertelli, A; Bertelli, AA; Das, DK; Imamura, G; Maulik, N; Otani, H | 1 |
7 review(s) available for resveratrol and Cardiovascular Stroke
| Article | Year |
|---|---|
A Comprehensive Analysis of the Efficacy of Resveratrol in Atherosclerotic Cardiovascular Disease, Myocardial Infarction and Heart Failure.
Topics: Animals; Atherosclerosis; Cardiovascular Diseases; Heart Failure; Humans; Myocardial Infarction; Resveratrol | 2021 |
Potential of natural products in the treatment of myocardial infarction: focus on molecular mechanisms.
Topics: Antioxidants; Biological Products; Free Radicals; Humans; Myocardial Infarction; Resveratrol | 2023 |
Antioxidant Cardioprotection against Reperfusion Injury: Potential Therapeutic Roles of Resveratrol and Quercetin.
Topics: Antioxidants; Humans; Myocardial Infarction; Myocardial Reperfusion Injury; Percutaneous Coronary Intervention; Quercetin; Reperfusion Injury; Resveratrol | 2022 |
Resveratrol and Cardiac Fibrosis Prevention and Treatment.
Topics: Animals; Fibrosis; Heart; Humans; Myocardial Infarction; Myocardium; Resveratrol; Stilbenes | 2022 |
AMPK in cardiac fibrosis and repair: Actions beyond metabolic regulation.
Topics: Aging; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Berberine; Cardiomegaly; Extracellular Matrix Proteins; Fibrosis; Gene Expression Regulation; Humans; Metformin; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Resveratrol; Ribonucleotides; Signal Transduction; Stilbenes; Thiazolidinediones; Wound Healing | 2016 |
Resveratrol: a promising agent in promoting cardioprotection against coronary heart disease.
Topics: Animals; Coronary Disease; Diabetes Mellitus; Endothelial Cells; Glucose; Glucose Transporter Type 4; Heart; Humans; Hypercholesterolemia; Myocardial Infarction; Nitric Oxide; Nitric Oxide Synthase Type III; Resveratrol; Stilbenes; Vascular Endothelial Growth Factor A | 2009 |
Therapeutic potential of resveratrol: the in vivo evidence.
Topics: Aging; Animals; Heart Diseases; Humans; Inflammation; Myocardial Infarction; Neoplasms; Protective Agents; Resveratrol; Stilbenes; Stroke | 2006 |
1 trial(s) available for resveratrol and Cardiovascular Stroke
| Article | Year |
|---|---|
Cardioprotection by resveratrol: A human clinical trial in patients with stable coronary artery disease.
Topics: Aged; Antioxidants; Brachial Artery; Coronary Artery Disease; Double-Blind Method; Endothelium, Vascular; Erythrocyte Deformability; Female; Humans; Male; Myocardial Infarction; Placebos; Platelet Aggregation; Resveratrol; Stilbenes; Vasodilation; Ventricular Function, Left | 2012 |
63 other study(ies) available for resveratrol and Cardiovascular Stroke
| Article | Year |
|---|---|
Resveratrol Pretreatment Inhibits Myocardial Apoptosis in Rats Following Coronary Microembolization via Inducing the PI3K/Akt/GSK-3β Signaling Cascade.
Topics: Animals; Apoptosis; Chromones; Disease Models, Animal; Glycogen Synthase Kinase 3 beta; Male; Morpholines; Myocardial Infarction; Myocytes, Cardiac; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction | 2021 |
Establishment of fingerprint and mechanism of anti-myocardial ischemic effect of Syringa pinnatifolia.
Topics: Animals; bcl-2-Associated X Protein; Caspase 3; Creatine Kinase; Eosine Yellowish-(YS); Flavonoids; Hematoxylin; Isoenzymes; Lactate Dehydrogenases; Myocardial Infarction; Myocardial Ischemia; Myocardium; Myocytes, Cardiac; Plant Extracts; Proto-Oncogene Proteins c-bcl-2; Rats; Resveratrol; Syringa; Terpenes | 2022 |
[Resveratrol pretreatment improves mitochondrial function and alleviates myocardial ischemia-reperfusion injury by up-regulating mi R-20b-5p to inhibit STIM2].
Topics: Adenosine Triphosphate; Animals; Antagomirs; bcl-2-Associated X Protein; Caspase 3; Glucose; MicroRNAs; Mitochondria, Heart; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Oxygen; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; Stromal Interaction Molecule 2 | 2022 |
Changes of Metabolic Phenotype of Cardiac Progenitor Cells During Differentiation: Neutral Effect of Stimulation of AMP-Activated Protein Kinase.
Topics: AMP-Activated Protein Kinase Kinases; Animals; Ataxin-1; Biphenyl Compounds; Cell Differentiation; Cell Proliferation; Gene Expression Regulation, Developmental; Glucose; Glucose Transporter Type 1; Glutamine; Glycolysis; Heart Injuries; Humans; Mice; Mitochondria; Monocarboxylic Acid Transporters; Muscle Proteins; Myocardial Infarction; Myocytes, Cardiac; Oxidative Phosphorylation; Phosphofructokinase-2; Protein Kinases; Pyrones; Rats; Resveratrol; Thiophenes | 2019 |
Protective role of poly(lactic-co-glycolic) acid nanoparticle loaded with resveratrol against isoproterenol-induced myocardial infarction.
Topics: Animals; Antioxidants; Biocompatible Materials; Cardiotonic Agents; Disease Models, Animal; Isoproterenol; Male; Myocardial Infarction; Nanoparticles; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar; Resveratrol | 2020 |
Engineered resveratrol-loaded fibrous scaffolds promotes functional cardiac repair and regeneration through Thioredoxin-1 mediated VEGF pathway.
Topics: Animals; Mice; Myocardial Infarction; Myocardium; Regeneration; Resveratrol; Thioredoxins; Vascular Endothelial Growth Factor A | 2021 |
Resveratrol Confers Protection Against Ischemia/Reperfusion Injury by Increase of Angiotensin (1-7) Expression in a Rat Model of Myocardial Hypertrophy.
Topics: Angiotensin I; Animals; Disease Models, Animal; Hypertrophy, Left Ventricular; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Peptide Fragments; Proto-Oncogene Mas; Rats, Wistar; Resveratrol; Tachycardia, Ventricular; Ventricular Fibrillation | 2021 |
Comparative and Combinatorial Effects of Resveratrol and Sacubitril/Valsartan alongside Valsartan on Cardiac Remodeling and Dysfunction in MI-Induced Rats.
Topics: Aminobutyrates; Animals; Biphenyl Compounds; Drug Combinations; Drug Interactions; Fibrosis; Humans; Male; Myocardial Infarction; Oxidative Stress; Rats; Rats, Sprague-Dawley; Resveratrol; Valsartan; Ventricular Function, Left; Ventricular Remodeling | 2021 |
Resveratrol improves cardiac function and exercise performance in MI-induced heart failure through the inhibition of cardiotoxic HETE metabolites.
Topics: Animals; Chromatography, Liquid; Heart Failure; Hydroxyeicosatetraenoic Acids; Male; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley; Resveratrol; Spectrometry, Mass, Electrospray Ionization | 2018 |
Resveratrol protects against isoproterenol induced myocardial infarction in rats through VEGF-B/AMPK/eNOS/NO signalling pathway.
Topics: Animals; Dose-Response Relationship, Drug; Isoproterenol; Male; Myocardial Infarction; Myocytes, Cardiac; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphorylation; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Structure-Activity Relationship; Vascular Endothelial Growth Factor B | 2019 |
Protective Effect of Resveratrol against Ischemia-Reperfusion Injury via Enhanced High Energy Compounds and eNOS-SIRT1 Expression in Type 2 Diabetic Female Rat Heart.
Topics: Adenosine Triphosphate; Animals; Cardiotonic Agents; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Energy Metabolism; Female; Gene Expression; Magnetic Resonance Spectroscopy; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphocreatine; Rats; Rats, Wistar; Resveratrol; Sirtuin 1 | 2019 |
Resveratrol protects myocardial apoptosis induced by ischemia-reperfusion in rats with acute myocardial infarction via blocking P13K/Akt/e-NOS pathway.
Topics: Acute Disease; Animals; Apoptosis; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinases; Protective Agents; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Resveratrol | 2019 |
Resveratrol Attenuates Cardiomyocyte Apoptosis in Rats Induced by Coronary Microembolization Through SIRT1-Mediated Deacetylation of p53.
Topics: Acetylation; Animals; Apoptosis; Apoptosis Regulatory Proteins; Disease Models, Animal; Embolization, Therapeutic; Male; Myocardial Infarction; Myocytes, Cardiac; Protein Processing, Post-Translational; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Sirtuin 1; Tumor Suppressor Protein p53 | 2019 |
Cardioprotective effect of resveratrol and resveratroloside.
Topics: Animals; Cardiotonic Agents; Dose-Response Relationship, Drug; Glucosides; Infusions, Parenteral; Male; Myocardial Infarction; Rats; Rats, Wistar; Reference Standards; Resveratrol; Stilbenes; Treatment Outcome | 2013 |
Resveratrol, an activator of SIRT1, upregulates AMPK and improves cardiac function in heart failure.
Topics: AMP-Activated Protein Kinases; Animals; Cell Line; Cells, Cultured; Heart Failure; Male; Mice; Myocardial Infarction; Myocytes, Cardiac; Niacinamide; Rats; Resveratrol; Sirtuin 1; Stilbenes; Up-Regulation; Ventricular Function | 2014 |
Antiaging properties of a grape-derived antioxidant are regulated by mitochondrial balance of fusion and fission leading to mitophagy triggered by a signaling network of Sirt1-Sirt3-Foxo3-PINK1-PARKIN.
Topics: Aging; Animals; Antioxidants; Apoptosis; Blotting, Western; Fluorescent Antibody Technique; Forkhead Box Protein O3; Forkhead Transcription Factors; Glutathione; Heart Ventricles; In Vitro Techniques; Intracellular Space; Male; Mitochondrial Dynamics; Mitophagy; Myocardial Infarction; Myocardial Ischemia; Myocardium; Myocytes, Cardiac; Protein Kinases; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; Signal Transduction; Sirtuins; Stilbenes; Ubiquitin-Protein Ligases; Vitis | 2014 |
Resveratrol attenuates the inflammatory reaction induced by ischemia/reperfusion in the rat heart.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Creatine Kinase; Disease Models, Animal; Inflammation; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Neutrophil Infiltration; Rats; Resveratrol; Stilbenes; Tumor Necrosis Factor-alpha | 2014 |
Ex vivo molecular rejuvenation improves the therapeutic activity of senescent human cardiac stem cells in a mouse model of myocardial infarction.
Topics: Animals; Cellular Senescence; Disease Models, Animal; Female; Humans; Mice; Mice, SCID; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Resveratrol; Signal Transduction; Sirolimus; Stem Cell Transplantation; Stilbenes | 2014 |
Long-term oral resveratrol intake provides nutritional preconditioning against myocardial ischemia/reperfusion injury: involvement of VDAC1 downregulation.
Topics: Administration, Oral; Animals; Apoptosis; Cardiotonic Agents; Caspase 3; Cytochromes c; Down-Regulation; Gene Expression Regulation; Heart; Ischemic Preconditioning, Myocardial; Mice; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardial Reperfusion Injury; Organ Culture Techniques; Resveratrol; Stilbenes; Voltage-Dependent Anion Channel 1 | 2015 |
Resveratrol Upregulates Cardiac SDF-1 in Mice with Acute Myocardial Infarction through the Deacetylation of Cardiac p53.
Topics: Acetylation; Animals; Cell Hypoxia; Chemokine CXCL12; Fibrosis; Gene Silencing; Heart Function Tests; Heart Ventricles; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Resveratrol; Sirtuin 1; Stilbenes; Tumor Suppressor Protein p53; Ultrasonography; Up-Regulation | 2015 |
Combined 1,25-Dihydroxy-vitamin D and Resveratrol: A Novel Therapeutic Approach to Ameliorate Ischemia Reperfusion-Induced Myocardial Injury.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arrhythmias, Cardiac; Calcium; Drug Therapy, Combination; Male; Myocardial Infarction; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Reperfusion Injury; Resveratrol; RNA, Messenger; Stilbenes; Vitamin D; Vitamins | 2015 |
Resveratrol is equipotent to perindopril in attenuating post-infarct cardiac remodeling and contractile dysfunction in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Male; Myocardial Contraction; Myocardial Infarction; Perindopril; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2016 |
Resveratrol attenuates myocardial ischemia/reperfusion injury through up-regulation of vascular endothelial growth factor B.
Topics: Animals; Antioxidants; Apoptosis; Cardiotonic Agents; Cell Line; Creatine Kinase, MB Form; Gene Expression Regulation; Glycogen Synthase Kinase 3 beta; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Myocytes, Cardiac; Organ Culture Techniques; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; RNA, Small Interfering; Signal Transduction; Stilbenes; Superoxide Dismutase; Vascular Endothelial Growth Factor B; Ventricular Function, Left | 2016 |
Resveratrol-Mediated Expression of KLF15 in the Ischemic Myocardium is Associated with an Improved Cardiac Phenotype.
Topics: Animals; Antioxidant Response Elements; Antioxidants; Disease Models, Animal; Kruppel-Like Transcription Factors; Male; Myocardial Infarction; Myocardium; NF-E2-Related Factor 2; Oxidation-Reduction; Oxidative Stress; Phenotype; Rats, Sprague-Dawley; Resveratrol; RNA, Messenger; Stilbenes; Time Factors; Up-Regulation; Ventricular Remodeling | 2017 |
Resveratrol activates endogenous cardiac stem cells and improves myocardial regeneration following acute myocardial infarction.
Topics: Animals; Antigens, Ly; Apoptosis; Biomarkers; Chemokine CXCL12; Disease Models, Animal; Male; Membrane Proteins; Mice; Myoblasts, Cardiac; Myocardial Infarction; Myocardium; Neovascularization, Physiologic; Regeneration; Resveratrol; Stem Cells; Stilbenes; Vascular Endothelial Growth Factor A | 2017 |
Strategic targets to induce neovascularization by resveratrol in hypercholesterolemic rat myocardium: role of caveolin-1, endothelial nitric oxide synthase, hemeoxygenase-1, and vascular endothelial growth factor.
Topics: Animals; Antioxidants; Blotting, Western; Caveolin 1; Coronary Circulation; Heart; Heme Oxygenase-1; Hypercholesterolemia; Immunohistochemistry; Male; Mice; Mice, Transgenic; Myocardial Infarction; Myocardium; Neovascularization, Physiologic; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Vascular Endothelial Growth Factor A | 2008 |
Resveratrol attenuates ventricular arrhythmias and improves the long-term survival in rats with myocardial infarction.
Topics: Administration, Oral; Animals; Calcium Channels, L-Type; Cardiac Pacing, Artificial; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrocardiography; KATP Channels; Male; Myocardial Infarction; Patch-Clamp Techniques; Phytoalexins; Prostheses and Implants; Rats; Rats, Sprague-Dawley; Resveratrol; Sesquiterpenes; Stilbenes; Survival Rate; Tachycardia, Ventricular; Telemetry; Terpenes; Time Factors; Ventricular Fibrillation; Ventricular Remodeling | 2008 |
Cardioprotective and antiarrhythmic effects of resveratrol--a modern perspective on an old treatment: editorial to "resveratrol attenuates ventricular arrhythmias and improves the long-term survival in rats with myocardial infarction" by Chen et al.
Topics: Animals; Anti-Arrhythmia Agents; Cardiotonic Agents; Drug Therapy; Humans; Myocardial Infarction; Rats; Resveratrol; Stilbenes; Survival Rate; Time Factors; Ventricular Fibrillation; Ventricular Flutter | 2008 |
Mechanism for resveratrol-induced cardioprotection against reperfusion injury involves glycogen synthase kinase 3beta and mitochondrial permeability transition pore.
Topics: Animals; Blotting, Western; Cardiotonic Agents; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Immunoprecipitation; In Vitro Techniques; Male; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Mitochondrial Swelling; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Rats; Rats, Wistar; Resveratrol; Stilbenes | 2009 |
Co-ordinated autophagy with resveratrol and γ-tocotrienol confers synergetic cardioprotection.
Topics: Animals; Antioxidants; Apoptosis; Autophagy; Cardiotonic Agents; Chromans; Drug Synergism; Male; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Resveratrol; Signal Transduction; Stilbenes; Vitamin E | 2010 |
Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure.
Topics: Adult; Animals; Cardiomyopathy, Dilated; Cell Nucleus; Cell Survival; Cells, Cultured; Chronic Disease; Cricetinae; Disease Models, Animal; Enzyme Activation; Heart Failure; Humans; Male; Mesocricetus; Mice; Muscle Fibers, Skeletal; Myocardial Infarction; Myocytes, Cardiac; Oxidative Stress; Phenols; Plant Extracts; Rats; Resveratrol; Sirtuin 1; Stilbenes; Superoxide Dismutase | 2010 |
Impaired macrophage migration inhibitory factor-AMP-activated protein kinase activation and ischemic recovery in the senescent heart.
Topics: Aging; AMP-Activated Protein Kinases; Animals; Down-Regulation; Enzyme Inhibitors; Hypoxia-Inducible Factor 1, alpha Subunit; Intramolecular Oxidoreductases; Macrophage Migration-Inhibitory Factors; Mice; Mice, Knockout; Myocardial Infarction; Myocardial Ischemia; Myocardium; Myocytes, Cardiac; Phenotype; Phosphorylation; Resveratrol; Signal Transduction; Stilbenes; Ultrasonography; Ventricular Function, Left | 2010 |
Red wine antioxidant resveratrol-modified cardiac stem cells regenerate infarcted myocardium.
Topics: Animals; Antioxidants; Chemokine CXCL12; Green Fluorescent Proteins; Heart Function Tests; Male; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley; Regeneration; Resveratrol; Stem Cell Transplantation; Stem Cells; Stilbenes; Wine | 2010 |
Favorable effects of resveratrol on sympathetic neural remodeling in rats following myocardial infarction.
Topics: Animals; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Arrhythmias, Cardiac; Biomarkers; Heart Ventricles; Macrophages; Male; Myocardial Infarction; Myocardium; Nerve Growth Factor; Neurons; Oxidative Stress; Random Allocation; Rats; Rats, Sprague-Dawley; Resveratrol; Severity of Illness Index; Stilbenes; Sympathetic Nervous System | 2010 |
Reduction of blood cholesterol and ischemic injury in the hypercholesteromic rabbits with modified resveratrol, longevinex. [corrected]
Topics: Animals; Anticholesteremic Agents; Arteriosclerosis; Biomarkers; Cholesterol; Disease Models, Animal; Down-Regulation; Hemodynamics; Hypercholesterolemia; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Rabbits; Resveratrol; Stilbenes; Time Factors; Ventricular Function, Left; Ventricular Pressure | 2011 |
Effects of Longevinex (modified resveratrol) on cardioprotection and its mechanisms of action.
Topics: Animals; Autophagy; Cardiotonic Agents; Forkhead Transcription Factors; Heart; In Vitro Techniques; Male; Myocardial Infarction; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Resveratrol; Sirtuin 1; Stilbenes; Ventricular Function, Left | 2010 |
Is red wine a SAFE sip away from cardioprotection? Mechanisms involved in resveratrol- and melatonin-induced cardioprotection.
Topics: Animals; Blotting, Western; In Vitro Techniques; Male; Melatonin; Mice; Myocardial Infarction; Myocardium; Phosphorylation; Rats; Rats, Wistar; Receptors, Tumor Necrosis Factor, Type II; Resveratrol; STAT3 Transcription Factor; Stilbenes; Wine | 2011 |
Regeneration of infarcted myocardium with resveratrol-modified cardiac stem cells.
Topics: Animals; Antioxidants; Biomarkers; Cell Proliferation; Cell- and Tissue-Based Therapy; Echocardiography; Heart; Male; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley; Regeneration; Resveratrol; Stem Cell Transplantation; Stem Cells; Stilbenes | 2012 |
Resveratrol protects left ventricle by increasing adenylate kinase and isocitrate dehydrogenase activities in rats with myocardial infarction.
Topics: Adenylate Kinase; Animals; Antioxidants; Blotting, Western; Cardiotonic Agents; Disease Models, Animal; Electrophoresis, Gel, Two-Dimensional; Energy Metabolism; Enzyme Activation; Immunohistochemistry; Isocitrate Dehydrogenase; Male; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Ventricular Remodeling | 2011 |
Statin administration does not improve the mobilization of very small embryonic-like stem cells (VSELs) in contrast to resveratrol treatment in a murine model of acute myocardial infarction.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Movement; Combined Modality Therapy; Embryonic Stem Cells; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Resveratrol; Stem Cell Transplantation; Stilbenes; Treatment Outcome | 2012 |
Resveratrol reverses remodeling in hearts with large, old myocardial infarctions through enhanced autophagy-activating AMP kinase pathway.
Topics: Adenosine Triphosphate; AMP-Activated Protein Kinases; Animals; Animals, Newborn; Apoptosis; Autophagy; Cells, Cultured; Densitometry; Energy Metabolism; Heart Failure; Heart Function Tests; Male; Mice; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Resveratrol; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Sirtuin 1; Stilbenes; Superoxide Dismutase; TOR Serine-Threonine Kinases; Vacuoles; Ventricular Remodeling | 2013 |
Resveratrol protects myocardial ischemia-reperfusion injury through both NO-dependent and NO-independent mechanisms.
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Coronary Disease; Creatine Kinase; Gene Expression; Heart Rate; L-Lactate Dehydrogenase; Models, Animal; Myocardial Infarction; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Resveratrol; RNA, Messenger; Stilbenes | 2004 |
Pharmacological preconditioning with resveratrol: role of CREB-dependent Bcl-2 signaling via adenosine A3 receptor activation.
Topics: Adenosine A3 Receptor Antagonists; Animals; Apoptosis; bcl-Associated Death Protein; Carrier Proteins; Cyclic AMP Response Element-Binding Protein; Dihydropyridines; Heart; Male; Myocardial Infarction; Myocytes, Cardiac; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A3; Resveratrol; Signal Transduction; Stilbenes; Theophylline | 2005 |
Cardiology patient pages. Red wine and your heart.
Topics: Alcohol Drinking; Animals; Antioxidants; Arteriosclerosis; Cohort Studies; Cricetinae; Dose-Response Relationship, Drug; Female; Fibrinolytic Agents; Flavonoids; Follow-Up Studies; Gene Expression Regulation; Humans; Male; Middle Aged; Myocardial Infarction; Phenols; Phytotherapy; Polyphenols; Rabbits; Resveratrol; Risk; Stilbenes; Stroke; Wine | 2005 |
Resveratrol-mediated activation of cAMP response element-binding protein through adenosine A3 receptor by Akt-dependent and -independent pathways.
Topics: Adenosine A3 Receptor Antagonists; Animals; Apoptosis; Biotransformation; Blotting, Western; Cyclic AMP Response Element-Binding Protein; Dihydropyridines; Enzyme Inhibitors; Heart Function Tests; In Situ Nick-End Labeling; Male; Mitogen-Activated Protein Kinases; Myocardial Contraction; Myocardial Infarction; Myocytes, Cardiac; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2005 |
Resveratrol enhances neovascularization in the infarcted rat myocardium through the induction of thioredoxin-1, heme oxygenase-1 and vascular endothelial growth factor.
Topics: Animals; Collagen; Coronary Circulation; Coronary Vessels; Drug Combinations; Endothelial Cells; Heart Ventricles; Heme Oxygenase-1; Humans; In Vitro Techniques; Laminin; Male; Metalloporphyrins; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Myocytes, Smooth Muscle; Neovascularization, Physiologic; Organ Size; Proteoglycans; Protoporphyrins; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Thioredoxins; Vascular Endothelial Growth Factor A | 2005 |
The introduction of the stilbene synthase gene enhances the natural antiradical activity of Lycopersicon esculentum mill.
Topics: Acyltransferases; Animals; Antioxidants; Apoptosis; Diet; Electron Spin Resonance Spectroscopy; Free Radicals; Lipid Peroxidation; Male; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Oxidative Stress; Plants, Genetically Modified; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Resveratrol; Solanum lycopersicum; Stilbenes | 2006 |
Resveratrol ameliorates myocardial damage by inducing vascular endothelial growth factor-angiogenesis and tyrosine kinase receptor Flk-1.
Topics: Angiogenesis Inducing Agents; Animals; Anti-Inflammatory Agents, Non-Steroidal; DNA; Heart; Heart Function Tests; Male; Microcirculation; Molecular Structure; Myocardial Infarction; Myocardium; Neovascularization, Physiologic; NF-kappa B; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Protein Binding; Rats; Rats, Sprague-Dawley; Resveratrol; Sp1 Transcription Factor; Stilbenes; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Ventricular Function, Left | 2006 |
Potentiation of a survival signal in the ischemic heart by resveratrol through p38 mitogen-activated protein kinase/mitogen- and stress-activated protein kinase 1/cAMP response element-binding protein signaling.
Topics: Animals; Cardiotonic Agents; Cyclic AMP Response Element-Binding Protein; Enzyme Inhibitors; In Vitro Techniques; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinases; Myocardial Infarction; Myocardial Ischemia; Myocardium; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Stilbenes | 2006 |
Cardioprotective effect of resveratrol via HO-1 expression involves p38 map kinase and PI-3-kinase signaling, but does not involve NFkappaB.
Topics: Animals; Apoptosis; Cardiotonic Agents; Heart; Heme Oxygenase-1; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Male; Metalloporphyrins; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Kinase Inhibitors; Protoporphyrins; Rats; Resveratrol; Signal Transduction; Stilbenes | 2006 |
Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic rat.
Topics: Animals; Apoptosis; beta Catenin; Drug Therapy, Combination; Gene Expression Regulation; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipid Metabolism; Male; Myocardial Infarction; Nitric Oxide Synthase Type III; Phosphorylation; Platelet Endothelial Cell Adhesion Molecule-1; Protein Transport; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Resveratrol; RNA, Messenger; Stilbenes; Vascular Endothelial Growth Factor A | 2007 |
Attenuation of ischemia/reperfusion injury in rats by the anti-inflammatory action of resveratrol.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Blood Pressure; Cell Adhesion Molecules; Enzyme Induction; Heart Function Tests; In Situ Nick-End Labeling; Male; Malondialdehyde; Myocardial Infarction; Myocardial Reperfusion Injury; Nitric Oxide; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Resveratrol; RNA, Messenger; Stilbenes | 2006 |
Acute dilatation to phytoestrogens and estrogen receptor subtypes expression in small arteries from women with coronary heart disease.
Topics: Aged; Arteries; Case-Control Studies; Endothelium, Vascular; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Genistein; Humans; Middle Aged; Myocardial Infarction; Phenols; Phytoestrogens; Postmenopause; Pyrazoles; Resveratrol; Stilbenes; Subcutaneous Fat, Abdominal; Vasodilation; Vasodilator Agents | 2008 |
Effects of resveratrol (trans-3,5,4'-trihydroxystilbene) treatment on cardiac remodeling following myocardial infarction.
Topics: Animals; Cardiotonic Agents; Echocardiography; Hemodynamics; Male; Myocardial Infarction; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Stilbenes; Ventricular Remodeling | 2007 |
Protective mechanisms of resveratrol against ischemia-reperfusion-induced damage in hearts obtained from Zucker obese rats: the role of GLUT-4 and endothelin.
Topics: Animals; Antioxidants; Apoptosis; Blood Glucose; Blood Pressure; Electrocardiography; Endothelin-1; Glucose Transporter Type 4; Heart Rate; In Situ Nick-End Labeling; In Vitro Techniques; Insulin; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Obesity; Rats; Rats, Zucker; Resveratrol; Signal Transduction; Stilbenes | 2008 |
The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury.
Topics: Animals; Antioxidants; Free Radicals; Heart; In Vitro Techniques; Male; Malondialdehyde; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Peroxides; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Wine | 1999 |
Myocardial protection by protykin, a novel extract of trans-resveratrol and emodin.
Topics: Animals; Antioxidants; Blood Pressure; Coronary Vessels; Emodin; Fluoresceins; Free Radical Scavengers; Gamma Rays; Hydroxyl Radical; Male; Malondialdehyde; Myocardial Infarction; Myocardial Ischemia; Oxidative Stress; Peroxides; Polygonaceae; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Resveratrol; Stilbenes | 2000 |
Myocardial protection with red wine extract.
Topics: Animals; Antioxidants; Blood Pressure; Drug Interactions; Ethanol; Free Radical Scavengers; Heart; In Vitro Techniques; Male; Malondialdehyde; Myocardial Contraction; Myocardial Infarction; Perfusion; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Resveratrol; Stilbenes; Time Factors; Wine | 2000 |
Does resveratrol induce pharmacological preconditioning?
Topics: Adenosine; Animals; Antioxidants; Cardiovascular Physiological Phenomena; Heart; Ischemic Preconditioning, Myocardial; Male; Muscle Contraction; Myocardial Infarction; Myocardial Ischemia; Myocardium; Phosphates; Phosphorylation; Rats; Rats, Sprague-Dawley; Recovery of Function; Regional Blood Flow; Reperfusion Injury; Resveratrol; Stilbenes | 2000 |
Beneficial effects of astringinin, a resveratrol analogue, on the ischemia and reperfusion damage in rat heart.
Topics: Animals; Antioxidants; Free Radical Scavengers; Heart; Hemodynamics; L-Lactate Dehydrogenase; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Nitrates; Nitric Oxide; Nitrites; Rats; Resveratrol; Stilbenes; Tachycardia, Ventricular; Ventricular Fibrillation | 2001 |
Effects of resveratrol, a flavinoid found in red wine, on infarct size in an experimental model of ischemia/reperfusion.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Blood Pressure; Body Weight; Flavonoids; Heart Rate; Heart Ventricles; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Rabbits; Regional Blood Flow; Resveratrol; Risk Factors; Stilbenes; Wine | 2001 |
Pharmacological preconditioning with resveratrol: role of nitric oxide.
Topics: Animals; Apoptosis; Enzyme Inhibitors; Gene Expression; Guanidines; Heart Ventricles; Ischemic Preconditioning; Malondialdehyde; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Resveratrol; RNA, Messenger; Stilbenes | 2002 |
Pharmacological preconditioning with resveratrol: an insight with iNOS knockout mice.
Topics: Animals; Apoptosis; Enzyme Inhibitors; Gene Expression; Guanidines; Heart; Ischemic Preconditioning; Kinetics; Male; Malondialdehyde; Mice; Mice, Knockout; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oxidative Stress; Resveratrol; RNA, Messenger; Stilbenes | 2002 |